Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Cash & Equivalents: 2022-2024

Historic Cash & Equivalents for NewGenIvf (NIVF) over the last 3 years, with FY2024 value amounting to $457740.0.

  • NewGenIvf's Cash & Equivalents changed N/A to $295.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $295.3 billion, marking a year-over-year change of. This contributed to the annual value of $457740.0 for FY2024, which is 74603.73% up from last year.
  • Latest data reveals that NewGenIvf reported Cash & Equivalents of $457740.0 as of FY2024, which was up 74603.73% from $54104.0 recorded in FY2023.
  • Over the past 5 years, NewGenIvf's Cash & Equivalents peaked at $457740.0 during FY2024, and registered a low of $27556.0 during FY2022.
  • In the last 3 years, NewGenIvf's Cash & Equivalents had a median value of $54104.0 in 2023 and averaged $179800.0.
  • In the last 5 years, NewGenIvf's Cash & Equivalents surged by 9634.2% in 2023 and then surged by 74603.73% in 2024.
  • Annual analysis of 3 years shows NewGenIvf's Cash & Equivalents stood at $27556.0 in 2022, then soared by 96.34% to $54104.0 in 2023, then surged by 746.04% to $457740.0 in 2024.
  • Its Cash & Equivalents stands at $457740.0 for FY2024, versus $54104.0 for FY2023 and $27556.0 for FY2022.